Cargando…
Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China
Zijian Feng and colleagues argue that sustained elimination of SARS-CoV-2 in China offers flexibility in covid-19 vaccination policy and discuss the anticipated challenges and systematic monitoring necessary to keep the immunisation component of the response on track
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634348/ https://www.ncbi.nlm.nih.gov/pubmed/34853010 http://dx.doi.org/10.1136/bmj-2021-066125 |
_version_ | 1784608113975885824 |
---|---|
author | An, Zhijie Wang, Fuzhen Pan, An Yin, Zundong Rodewald, Lance Feng, Zijian |
author_facet | An, Zhijie Wang, Fuzhen Pan, An Yin, Zundong Rodewald, Lance Feng, Zijian |
author_sort | An, Zhijie |
collection | PubMed |
description | Zijian Feng and colleagues argue that sustained elimination of SARS-CoV-2 in China offers flexibility in covid-19 vaccination policy and discuss the anticipated challenges and systematic monitoring necessary to keep the immunisation component of the response on track |
format | Online Article Text |
id | pubmed-8634348 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86343482021-12-10 Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China An, Zhijie Wang, Fuzhen Pan, An Yin, Zundong Rodewald, Lance Feng, Zijian BMJ Analysis Zijian Feng and colleagues argue that sustained elimination of SARS-CoV-2 in China offers flexibility in covid-19 vaccination policy and discuss the anticipated challenges and systematic monitoring necessary to keep the immunisation component of the response on track BMJ Publishing Group Ltd. 2021-12-02 /pmc/articles/PMC8634348/ /pubmed/34853010 http://dx.doi.org/10.1136/bmj-2021-066125 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Analysis An, Zhijie Wang, Fuzhen Pan, An Yin, Zundong Rodewald, Lance Feng, Zijian Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China |
title | Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China |
title_full | Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China |
title_fullStr | Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China |
title_full_unstemmed | Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China |
title_short | Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China |
title_sort | vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in china |
topic | Analysis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634348/ https://www.ncbi.nlm.nih.gov/pubmed/34853010 http://dx.doi.org/10.1136/bmj-2021-066125 |
work_keys_str_mv | AT anzhijie vaccinationstrategyandchallengesforconsolidatingsuccessfulcontainmentofcovid19withpopulationimmunityinchina AT wangfuzhen vaccinationstrategyandchallengesforconsolidatingsuccessfulcontainmentofcovid19withpopulationimmunityinchina AT panan vaccinationstrategyandchallengesforconsolidatingsuccessfulcontainmentofcovid19withpopulationimmunityinchina AT yinzundong vaccinationstrategyandchallengesforconsolidatingsuccessfulcontainmentofcovid19withpopulationimmunityinchina AT rodewaldlance vaccinationstrategyandchallengesforconsolidatingsuccessfulcontainmentofcovid19withpopulationimmunityinchina AT fengzijian vaccinationstrategyandchallengesforconsolidatingsuccessfulcontainmentofcovid19withpopulationimmunityinchina |